RxDoctor Payments Data

Rebecca Rose, MD

Family Medicine · Biloxi, MSNPI 1942439542

Payments from drug & device makers

$4,807in general payments, 2019–2025

Across 310 payments — averaging $15.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$539
  • AbbVie$475
  • GSK$469
  • Lilly USA, LLC$430
  • Amgen$311
  • Novo Nordisk$276
  • plus $2K from 33 others

What the payments were for

  • Food & beverage$4,807100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,807 in reported general payments places this provider in the 80th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$103,784
Medicare patients
282
Services billed
1,581

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide90$127,911
MounjaroTirzepatide63$75,091
JardianceEmpagliflozin46$52,644
TrulicityDulaglutide41$43,024
EliquisApixaban44$31,778
JanuviaSitagliptin Phosphate27$30,995
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$24,885
FarxigaDapagliflozin Propanediol13$16,292
MyrbetriqMirabegron13$15,488
XareltoRivaroxaban13$15,141
Repatha SyringeEvolocumab18$15,060
Janumet XrSitagliptin Phos/Metformin Hcl16$12,869
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$6,500
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$6,474
Fluticasone-SalmeterolFluticasone Propion/Salmeterol20$4,915

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$276$127,91190 claims
Lilly USA, LLCMounjaro, Trulicity$430$118,115104 claims
Boehringer IngelheimJardiance$71$52,64446 claims
MerckJanuvia, Janumet Xr$139$43,86543 claims
PfizerEliquis$539$31,77844 claims
GSKTrelegy Ellipta$469$24,88524 claims
AstraZenecaFarxiga, Symbicort$240$20,68427 claims
Astellas Pharma US IncMyrbetriq$67$15,48813 claims
Johnson & JohnsonXarelto$231$15,14113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Biloxi

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →